{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:12:53Z","timestamp":1772845973334,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier","isbn-type":[{"value":"9780323400169","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/b978-0-323-40016-9.00009-9","type":"book-chapter","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T14:37:47Z","timestamp":1527259067000},"page":"233-259","source":"Crossref","is-referenced-by-count":26,"title":["Advances in antibiotic nanotherapy"],"prefix":"10.1016","author":[{"given":"M.C.","family":"Teixeira","sequence":"first","affiliation":[]},{"given":"E.","family":"Sanchez-Lopez","sequence":"additional","affiliation":[]},{"given":"M.","family":"Espina","sequence":"additional","affiliation":[]},{"given":"A.C.","family":"Calpena","sequence":"additional","affiliation":[]},{"given":"Amelia M.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"F.J.","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"M.L.","family":"Garcia","sequence":"additional","affiliation":[]},{"given":"Eliana B.","family":"Souto","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib1","unstructured":"Control CoD. ANTIBIOTIC RESISTANCE THREATS in the United States. 2013."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/cc9997","article-title":"New treatment options against gram-negative organisms","volume":"15","author":"Bassetti","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/QCO.0000000000000251","article-title":"New therapeutic options for respiratory tract infections","volume":"29","author":"Bassetti","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib4","doi-asserted-by":"crossref","first-page":"e11818","DOI":"10.1371\/journal.pone.0011818","article-title":"A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections","volume":"5","author":"Hu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/383219a0","article-title":"Bacteria on the rampage","volume":"383","author":"Davies","year":"1996","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/35021219","article-title":"Molecular mechanisms that confer antibacterial drug resistance","volume":"406","author":"Walsh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QCO.0b013e3283483262","article-title":"Antibiotic stewardship: overcoming implementation barriers","volume":"24","author":"Bal","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.69554\/XDPS7260","article-title":"Antimicrobial resistance, infection control and planning for pandemics: the importance of knowledge transfer in healthcare resilience and emergency planning","volume":"6","author":"Cole","year":"2012","journal-title":"J. Bus. Contin. Emer. Plan."},{"issue":"Suppl 5","key":"10.1016\/B978-0-323-40016-9.00009-9_bib10","first-page":"S397","article-title":"Combating antimicrobial resistance: policy recommendations to save lives","volume":"52","author":"Spellberg","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/B978-0-323-40016-9.00009-9_bib11","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1093\/clinids\/24.Supplement_1.S139","article-title":"Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide","volume":"24","author":"Goldmann","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.meegid.2008.07.007","article-title":"The evolution of staphylococcus aureus","volume":"8","author":"Deurenberg","year":"2008","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib13","first-page":"999","article-title":"Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance","volume":"64","author":"Colgan","year":"2001","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2014.10.027","article-title":"Therapeutic strategies to combat antibiotic resistance","volume":"78","author":"Brooks","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tibtech.2012.06.004","article-title":"Antibacterial properties of nanoparticles","volume":"30","author":"Hajipour","year":"2012","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib16","first-page":"328","article-title":"Effects of salt stress on the antimicrobial drug resistance and protein profile of staphylococcus aureus","volume":"5","author":"Ganjian","year":"2012","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib17","first-page":"1475","article-title":"Antibiotic resistance: an overview of mechanisms and a paradigm shift","volume":"96","author":"Jayaraman","year":"2009","journal-title":"Curr. Sci."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11274-009-0211-3","article-title":"Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria","volume":"26","author":"Lara","year":"2010","journal-title":"World J. Microbiol. Biotechnol"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ja.2011.58","article-title":"Recent advances in materials for extended-release antibiotic delivery system","volume":"64","author":"Gao","year":"2011","journal-title":"J. Antibiot."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib20","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib21","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1046\/j.1365-2672.92.5s1.8.x","article-title":"Mechanisms of bacterial biocide and antibiotic resistance","volume":"92","author":"Poole","year":"2002","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib22","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1086\/513854","article-title":"Penicillin-binding protein-mediated resistance in pneumococci and staphylococci","volume":"179","author":"Chambers","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib24","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1128\/AAC.00915-06","article-title":"Prevalence in the United States of aac(6 ')-Ib-cr encoding a ciprofloxacin-modifying enzyme","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib25","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses","volume":"10","author":"Levy","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib26","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/AAC.48.7.2617-2623.2004","article-title":"Dihydropteroate synthase mutations in pneumocystis jiroveci can affect sulfamethoxazole resistance in a saccharomyces cerevisiae model","volume":"48","author":"Iliades","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib27","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/ph6121543","article-title":"Antimicrobial peptides","volume":"6","author":"Bahar","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/fmc.15.7","article-title":"Agents that inhibit bacterial biofilm formation","volume":"7","author":"Rabin","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/08927014.2014.889120","article-title":"Mini-review: antimicrobial peptides and enzymes as promising candidates to functionalize biomaterial surfaces","volume":"30","author":"Alves","year":"2014","journal-title":"Biofouling"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","article-title":"\u201cNanoantibiotics\u201d: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era","volume":"156","author":"Huh","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4161\/viru.2.5.17035","article-title":"The growing role of nanotechnology in combating infectious disease","volume":"2","author":"Blecher","year":"2011","journal-title":"Virulence."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib32","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1128\/JCM.44.4.1502-1508.2006","article-title":"Isothermal amplification and molecular typing of the obligate intracellular pathogen mycobacterium leprae isolated from tissues of unknown origins","volume":"44","author":"Groathouse","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib33","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/j.watres.2008.08.015","article-title":"Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications","volume":"42","author":"Li","year":"2008","journal-title":"Water Res."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/jam.13010","article-title":"Nanotechnology based anti-infectives to fight microbial intrusions","volume":"120","author":"Rai","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1039\/b715532h","article-title":"The use of nanoparticles in anti-microbial materials and their characterization","volume":"133","author":"Weir","year":"2008","journal-title":"Analyst"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib36","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.nantod.2014.06.003","article-title":"Nanomedicine in the management of microbial infection - overview and perspectives","volume":"9","author":"Zhu","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jhin.2014.09.009","article-title":"Nanomedicines for antimicrobial interventions","volume":"88","author":"Cavalieri","year":"2014","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3109\/03639045.2014.920025","article-title":"Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus","volume":"41","author":"Khameneh","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib39","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.2174\/138161282128150922175445","article-title":"Insights in nanoparticle-bacterium interactions: new frontiers to bypass bacterial resistance to antibiotics","volume":"21","author":"Diab","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib40","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.addr.2005.04.002","article-title":"Bacterial resistance to antibiotics: enzymatic degradation and modification","volume":"57","author":"Wright","year":"2005","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/02652049109021857","article-title":"Liposome-encapsulated antibiotics - preparation, drug release and antimicrobial activity against pseudomonas-aeruginosa","volume":"8","author":"Lagace","year":"1991","journal-title":"J. Microencapsul."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib42","first-page":"4","article-title":"Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis","author":"Alipour","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib43","first-page":"9","article-title":"Liposome-encapsulated ISMN: a novel nitric oxide-based therapeutic agent against staphylococcus aureus biofilms","author":"Jardeleza","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib44","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/alr.20083","article-title":"The effects of nitric oxide on staphylococcus aureus biofilm growth and its implications in chronic rhinosinusitis","volume":"1","author":"Jardeleza","year":"2011","journal-title":"Int. Forum Allergy Rhinol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib45","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/bm500422v","article-title":"Nanoparticle (star polymer) delivery of nitric oxide effectively negates pseudomonas aeruginosa biofilm formation","volume":"15","author":"Duong","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/03639045.2013.877483","article-title":"The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm","volume":"41","author":"Moghadas-Sharif","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib47","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1128\/AAC.02420-12","article-title":"High activity of fosfomycin and rifampin against methicillinresistant Staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model","volume":"58","author":"Mihailescu","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12223-013-0296-9","article-title":"Antimicrobial activity of tigecycline alone or in combination with rifampin against Staphylococcus epidermidis in biofilm","volume":"59","author":"Szczuka","year":"2014","journal-title":"Folia Microbiol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1590\/S0037-86822012000400011","article-title":"Rifampicin fails to eradicate mature biofilm formed by methicillin-resistant Staphylococcus aureus","volume":"45","author":"Reiter","year":"2012","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2007.11.035","article-title":"Antimicrobial effectiveness of liposomal polymyxin B against resistant gram-negative bacterial strains","volume":"355","author":"Alipour","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib51","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jac\/dkn059","article-title":"Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections","volume":"61","author":"Meers","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrm1104","article-title":"Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens","volume":"4","author":"Rosenberger","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/AAC.43.2.246","article-title":"Mechanism underlying levofloxacin uptake by human polymorphonuclear neutrophils","volume":"43","author":"Vazifeh","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.02.009","article-title":"Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections","volume":"43","author":"Abed","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.biomaterials.2010.08.076","article-title":"Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids","volume":"32","author":"Huang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib56","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.biomaterials.2005.11.031","article-title":"Drug\/device combinations for local drug therapies and infection prophylaxis","volume":"27","author":"Wu","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib57","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1007\/s11999-013-2988-5","article-title":"Chitosan sponges for local synergistic infection therapy: a pilot study","volume":"471","author":"Smith","year":"2013","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib58","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1016\/j.biomaterials.2010.05.005","article-title":"Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use","volume":"31","author":"Campoccia","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-642-00477-3_11","article-title":"Drug-eluting medical implants","author":"Zilberman","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib60","first-page":"13","article-title":"Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study","author":"Sorli","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib61","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.1021\/am403940d","article-title":"Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells","volume":"5","author":"Qi","year":"2013","journal-title":"Acs Appl. Mater. Interfaces"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib62","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1166\/jbn.2014.1852","article-title":"In Vivo Imaging of Infection Using a Bacteria-Targeting Optical Nanoprobe","volume":"10","author":"Tang","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2014.02.002","article-title":"Delivery of antibiotics with polymeric particles","volume":"78","author":"Xiong","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/jac\/dkr408","article-title":"In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria","volume":"67","author":"Leid","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib65","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1016\/j.biomaterials.2009.03.044","article-title":"The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies","volume":"30","author":"Hindi","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib66","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1039\/C5TB01527H","article-title":"Nanotechnology solutions to restore antibiotic activity","volume":"4","author":"Shimanovich","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib67","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1126\/science.7604262","article-title":"Common virulence factors for bacterial pathogenicity in plants and animals","volume":"268","author":"Rahme","year":"1995","journal-title":"Science"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib68","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1021\/ja211279u","article-title":"Lipase-sensitive polymeric triple-layered nanogel for \u201con-demand\u201d drug delivery","volume":"134","author":"Xiong","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib69","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.321.5887.356","article-title":"The bacteria fight back","volume":"321","author":"Taubes","year":"2008","journal-title":"Science"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1472-8206.2009.00692.x","article-title":"Emerging trends of nanomedicine - an overview","volume":"23","author":"Sandhiya","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2003.07.014","article-title":"Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery","volume":"277","author":"Dufresne","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-3659(00)00208-X","article-title":"pH-Sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery","volume":"68","author":"Risbud","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2010.04.026","article-title":"Potential neurotoxicity of nanoparticles","volume":"394","author":"Hu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/nn700191f","article-title":"Bactericidal efficacy of nitric oxide-releasing silica nanoparticles","volume":"2","author":"Hetrick","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1096\/fj.04-2747rev","article-title":"Nanomedicine: current status and future prospects","volume":"19","author":"Moghimi","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib76","article-title":"Morphological control of room-temperature ionic liquid templated mesoporous silica nanoparticles for controlled release of antibacterial agents","volume":"229","author":"Trewyn","year":"2005","journal-title":"Abstr Pap. Am. Chem. Soc"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib77","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/nl034396z","article-title":"Presenting vancomycin on nanoparticles to enhance antimicrobial activities","volume":"3","author":"Gu","year":"2003","journal-title":"Nano Lett."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib78","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/092986710790416290","article-title":"Development of nanoparticles for antimicrobial drug delivery","volume":"17","author":"Zhang","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.colsurfb.2015.03.049","article-title":"Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: antibiotic resistance tests and HaCat and NIH\/3T3 cell viability studies","volume":"129","author":"Severino","year":"2015","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib80","doi-asserted-by":"crossref","first-page":"754810","DOI":"10.1155\/2009\/754810","article-title":"On the toxicity of therapeutically used nanoparticles: an overview","volume":"2009","author":"El-Ansary","year":"2009","journal-title":"J. Toxicol"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yrtph.2007.07.006","article-title":"What do we (need to) know about the kinetic properties of nanoparticles in the body?","volume":"49","author":"Hagens","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib82","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/bm034130m","article-title":"Chitosan as antimicrobial agent: applications and mode of action","volume":"4","author":"Rabea","year":"2003","journal-title":"Biomacromolecules"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib83","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/138920208786847962","article-title":"Toxicogenomics to improve comprehension of the mechanisms underlying responses of in vitro and in vivo systems to nanomaterials: a review","volume":"9","author":"Poma","year":"2008","journal-title":"Curr. Genomics"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib84","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.taap.2008.06.026","article-title":"Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity","volume":"232","author":"Lei","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2013.10.014","article-title":"Advances in nanomedicines for malaria treatment","volume":"201-202","author":"Aditya","year":"2013","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.02.045","article-title":"Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals","volume":"317","author":"Muller","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib87","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejpb.2007.07.006","article-title":"Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation","volume":"68","author":"Muller","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib88","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1407.071110","article-title":"Transmission of bartonella henselae by Ixodes ricinus","volume":"14","author":"Cotte","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib89","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1289\/ehp.6851","article-title":"Ultrafine particle deposition in subjects with asthma","volume":"112","author":"Chalupa","year":"2004","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib90","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.fertnstert.2009.03.094","article-title":"Effects of fetal exposure to carbon nanoparticles on reproductive function in male offspring","volume":"93","author":"Yoshida","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib91","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.tiv.2008.08.009","article-title":"The effects of nanoparticles on mouse testis Leydig cells in vitro","volume":"22","author":"Komatsu","year":"2008","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_bib92","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejpb.2008.08.009","article-title":"Current in vitro methods in nanoparticle risk assessment: limitations and challenges","volume":"72","author":"Kroll","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_fur1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1389450033346920","article-title":"Fluoroquinolones: structure and target sites","volume":"4","author":"Higgins","year":"2003","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/B978-0-323-40016-9.00009-9_fur2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/605630","article-title":"Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship","volume":"49","author":"Roberts","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_fur3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jac\/dkp111","article-title":"Mutational analysis of quinolone resistance in the plasmid-encoded pentapeptide repeat proteins QnrA, QnrB and QnrS","volume":"63","author":"Rodriguez-Martinez","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/B978-0-323-40016-9.00009-9_fur4","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","article-title":"Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in plasmodium falciparum","volume":"94","author":"Triglia","year":"1997","journal-title":"Proc. Nat. Acad. Sci. U S A."}],"container-title":["Emerging Nanotechnologies in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323400169000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323400169000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T19:29:35Z","timestamp":1751657375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323400169000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780323400169"],"references-count":96,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-40016-9.00009-9","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}